Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: The Effect of Riboflavin in Crohn's Disease [NA]
Clinical trial investigating riboflavin in Crohn's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease [Phase 2]
Phase 2 trial update for Prochymal adult mesenchymal stem cells in moderate-to-severe Crohn's disease has completed.
-
FDA approval · 2020-03-31FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Entyvio (vedolizumab) submitted by Takeda Pharmaceuticals America, resulting in updated appr…
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Can Vitamin D Supplementation in People With Crohn's Disease Improve Symptoms as an Adjunct Therapy? [Phase 4]
A Phase 4 clinical trial update investigates whether vitamin D supplementation may improve symptoms in people with Crohn's disease and vitam…
-
EMA withdrawal · 2020-03-25EMA Withdrawn: Kromeya (adalimumab) — Fresenius Kabi Deutschland GmbH
EMA has withdrawn Kromeya (adalimumab) from Fresenius Kabi Deutschland GmbH, effective 2019, affecting multiple inflammatory diseases.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-03-25Clinical Trial Update: Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease [Phase 2, Phase 3]
A clinical trial investigating cannabidiol as an adjunct therapy for Crohn's disease (Phase 2/Phase 3) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: FMT in Pediatric Crohn's Disease [Phase 1, Phase 2]
Clinical trial update on fecal microbiota transplantation (FMT) in pediatric Crohn's disease across Phase 1 and Phase 2, completed.
-
CLINICAL_TRIALS research · 2020-03-04Clinical Trial Update: Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease [Phase 4]
A postmarketing phase 4 trial evaluating vedolizumab in lactating women with active ulcerative colitis or Crohn's disease to assess milk exp…
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD [Phase 3]
Phase 3 trial evaluating oral ferric maltol versus IV iron for iron deficiency anemia in inflammatory bowel disease completed with posted re…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Crohn's Allogeneic Transplant Study [Phase 2]
A Phase 2 allogeneic transplant study for Crohn's disease was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
A completed post-marketing study evaluating CT-P13 (infliximab) for standard of care treatment in inflammatory bowel diseases, including ulc…
-
FDA approval · 2020-02-12FDA Approved: MESALAMINE — Original Application (Northstar Rx LLC.)
FDA approved an original application for mesalamine (generic) submitted by Northstar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Corticosteroid Dosage for Crohn's Disease Flare [Phase 4]
Phase 4 clinical trial update related to corticosteroid dosage for Crohn's disease flare; trial terminated with results posted in 2020.
-
CLINICAL_TRIALS withdrawal · 2020-01-18Clinical Trial Update: Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD [Phase 4]
A phase 4 clinical trial investigating escalating adalimumab for prevention of relapse in inflammatory bowel disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease [Phase 3]
Phase III study of MLN0002 (300 mg) in Crohn's disease has completed; results posted in 2019.
-
FDA approval · 2019-12-06FDA Approved: AVSOLA — Original Application (Amgen, Inc)
FDA approved AVSOLA (infliximab-axxq) from Amgen as a biosimilar to infliximab, for the same indications as the reference product.
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease [Phase 3]
Phase 3 trial update on adipose-derived mesenchymal stem cells for inducing remission in perianal fistulizing Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)
Post-marketing observational study evaluating the impact of AbbVie's Patient Support Program on patient-reported outcomes and health resourc…
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator [NA]
A terminated clinical trial evaluated whether response to infliximab or adalimumab could be regained with an immunomodulator in inflammatory…
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Antibiotics and Hydroxychloroquine in Crohn's [Phase 2]
Phase 2 clinical trial assessing antibiotics and hydroxychloroquine for Crohn's disease has completed.
-
FDA approval · 2019-10-29FDA Approved: BUDESONIDE — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for Budesonide by Rite Aid Corporation, expanding or modifying the approval of this generic product.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 trial update evaluating a self-injection e-device for certolizumab pegol in several inflammatory diseases; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease [Phase 4]
Phase 4 trial update evaluating vedolizumab IV 300 mg for fistulizing Crohn's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease [Phase 3]
A Phase 3 trial of delayed-release rifaximin in Crohn's disease was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease [Phase 3]
A Phase 3 clinical trial evaluating delayed-release rifaximin for Crohn's disease was terminated with results posted in 2019.